![Carl Dambkowski](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Carl Dambkowski
Technik-/Wissenschafts-/F&E-Leiter bei
APOGEE THERAPEUTICS, INC.
Vermögen: 26 Mio $ am 30.06.2026
Profil
Carl Dambkowski is the founder of Novonate, Inc., founded in 2015.
Current jobs include Independent Director at Oruka Therapeutics, Inc. since 2024 and Chief Medical Officer at Apogee Therapeutics, Inc. since 2022.
Former jobs include Chief Medical Officer at QED Therapeutics, Inc. from 2021 to 2022, Chief Strategy Officer & EVP-Operations at Origin Biosciences, Inc. from 2018 to 2021, Chief Medical Officer at Navire Pharma, Inc. from 2020 to 2022, and Associate at McKinsey & Co., Inc. from 2016 to 2018.
Education includes graduate studies at The Trustees of Columbia University in The City of New York and undergraduate and doctorate degrees from Stanford University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.07.2026 | 169’873 ( 0.3% ) | 23 Mio $ | 30.06.2026 | |
0.08% | 12.06.2026 | 38’743 ( 0.08% ) | 4 Mio $ | 30.06.2026 |
Aktive Positionen von Carl Dambkowski
| Unternehmen | Position | Beginn |
|---|---|---|
| APOGEE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2022 |
Ehemalige bekannte Positionen von Carl Dambkowski
| Unternehmen | Position | Ende |
|---|---|---|
QED Therapeutics, Inc.
 QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2022 |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2022 |
Origin Biosciences, Inc.
 Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Corporate Officer/Principal | 01.06.2021 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | 01.03.2018 |
Novonate, Inc.
 Novonate, Inc. Medical SpecialtiesHealth Technology Manufactures lifebubble devices | Gründer | - |
Ausbildung von Carl Dambkowski
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
12
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novonate, Inc.
Novonate, Inc. Medical SpecialtiesHealth Technology Manufactures lifebubble devices | Health Technology |
QED Therapeutics, Inc.
QED Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Origin Biosciences, Inc.
Origin Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Navire Pharma, Inc.
Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
Apogee Therapeutics, Inc.
 Apogee Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops therapies for immunological and inflammatory disorders | Health Technology |
